Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA

Illumina

Status: Completed

Conditions: Detection and Genotyping of Factor V and Factor II Point Mutations

Study type: Observational

Funder types: Industry

Identifiers

NCT00959504

ILMN001

Details and patient eligibility

About

As an external validation test of the performance of the VeraCode Genotyping Test for Factor V and Factor II on the BeadXpress System, clinical trials will be conducted at three sites. This study will assess genotyping accuracy as compared to bidirectional sequencing and genotyping reproducibility across variables such as user, day, and site.

Enrollment: 275 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patient samples will be leftover EDTA-anticoagulated whole blood from patients referred for Factor V and/or Factor II testing.

Exclusion criteria

• There are no applicable exclusion criteria for this test, since the genomic sequence will not vary by ethnicity, gender, age or disease. Inappropriately stored blood samples will be excluded.